Foresee Pharmaceuticals Statistics
Total Valuation
TPEX:6576 has a market cap or net worth of TWD 12.07 billion. The enterprise value is 11.82 billion.
| Market Cap | 12.07B |
| Enterprise Value | 11.82B |
Important Dates
The next estimated earnings date is Tuesday, May 5, 2026.
| Earnings Date | May 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TPEX:6576 has 157.54 million shares outstanding. The number of shares has increased by 12.80% in one year.
| Current Share Class | 157.54M |
| Shares Outstanding | 157.54M |
| Shares Change (YoY) | +12.80% |
| Shares Change (QoQ) | +1.97% |
| Owned by Insiders (%) | 8.58% |
| Owned by Institutions (%) | 1.15% |
| Float | 108.93M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 27.98 |
| PB Ratio | 12.98 |
| P/TBV Ratio | 14.74 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -13.38 |
| EV / Sales | 27.41 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -13.98 |
Financial Position
The company has a current ratio of 3.44, with a Debt / Equity ratio of 0.25.
| Current Ratio | 3.44 |
| Quick Ratio | 1.89 |
| Debt / Equity | 0.25 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.27 |
| Interest Coverage | -154.90 |
Financial Efficiency
Return on equity (ROE) is -69.85% and return on invested capital (ROIC) is -35.68%.
| Return on Equity (ROE) | -69.85% |
| Return on Assets (ROA) | -31.07% |
| Return on Invested Capital (ROIC) | -35.68% |
| Return on Capital Employed (ROCE) | -84.20% |
| Weighted Average Cost of Capital (WACC) | 8.01% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.25 |
| Inventory Turnover | 0.83 |
Taxes
In the past 12 months, TPEX:6576 has paid 24.95 million in taxes.
| Income Tax | 24.95M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +19.50% in the last 52 weeks. The beta is 0.71, so TPEX:6576's price volatility has been lower than the market average.
| Beta (5Y) | 0.71 |
| 52-Week Price Change | +19.50% |
| 50-Day Moving Average | 80.47 |
| 200-Day Moving Average | 78.18 |
| Relative Strength Index (RSI) | 35.97 |
| Average Volume (20 Days) | 114,312 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:6576 had revenue of TWD 431.27 million and -883.15 million in losses. Loss per share was -5.70.
| Revenue | 431.27M |
| Gross Profit | 294.22M |
| Operating Income | -862.32M |
| Pretax Income | -858.20M |
| Net Income | -883.15M |
| EBITDA | -812.19M |
| EBIT | -862.32M |
| Loss Per Share | -5.70 |
Balance Sheet
The company has 479.52 million in cash and 231.74 million in debt, with a net cash position of 247.78 million or 1.57 per share.
| Cash & Cash Equivalents | 479.52M |
| Total Debt | 231.74M |
| Net Cash | 247.78M |
| Net Cash Per Share | 1.57 |
| Equity (Book Value) | 929.61M |
| Book Value Per Share | 5.90 |
| Working Capital | 699.41M |
Cash Flow
In the last 12 months, operating cash flow was -842.23 million and capital expenditures -2.96 million, giving a free cash flow of -845.19 million.
| Operating Cash Flow | -842.23M |
| Capital Expenditures | -2.96M |
| Depreciation & Amortization | 50.13M |
| Net Borrowing | -64.05M |
| Free Cash Flow | -845.19M |
| FCF Per Share | -5.37 |
Margins
Gross margin is 68.22%, with operating and profit margins of -199.95% and -204.78%.
| Gross Margin | 68.22% |
| Operating Margin | -199.95% |
| Pretax Margin | -198.99% |
| Profit Margin | -204.78% |
| EBITDA Margin | -188.32% |
| EBIT Margin | -199.95% |
| FCF Margin | n/a |
Dividends & Yields
TPEX:6576 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -12.80% |
| Shareholder Yield | -12.80% |
| Earnings Yield | -7.32% |
| FCF Yield | -7.00% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TPEX:6576 has an Altman Z-Score of 10.12 and a Piotroski F-Score of 3.
| Altman Z-Score | 10.12 |
| Piotroski F-Score | 3 |